Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mid-sized Players Dining Out on Big Pharma Leftovers

Jul 01 2004

• By Chris Morrison

Related Content

Are Late-Stage Deals Beginning to Lose Their Luster?

Jun 01 2004

Bioteching UCB-and Maybe Mid-Sized Pharma, Too

Jun 01 2004

Building a Sustainable BioPharma Industry--the European Way

Jul 01 2004

Early M&A: The Secret of Biotech's Success

Oct 01 2003

Surfaxin: Epitomizing Esteve

May 01 2003

Sleeping Giant: Europe's Slice of the Global UI Market

May 01 2003

Related Companies

Basilea Pharmaceutica Ltd.

Esteve Pharmaceuticals, S.A.

UCB S.A.

UCB S.A.

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Endo, Inc.

Zambon Company S.p.A.

Windtree Therapeutics, Inc.

Heidelberg Pharma AG

Merck & Co., Inc.

Warner Chilcott PLC

Additional Topics

Europe Strategy Business Strategies Deals BioPharmaceutical

More from Global Vision

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window